Explosion on Passenger Train in Quetta Injures Over 30 Security Concerns May Impact Pakistans Investment Climate Billionaire Bill Ackmans Pershing Square Adds Over 2 Billion in Microsoft Shares University of Manchester to Offer Work Placements Across All Degree Programs Oura Files Confidentially for IPO Expanding Health Wearable Market Reach Nvidia Earnings Set to Test Market Sentiment as Investors Focus on China Strategy and Political Commentary Global Stocks Rise Bond Yields Fall as USIran Talks Show Signs of Progress CZNC Q1 2026 Earnings Massive EPS Miss Shocks Analysts Stock Holds Steady Banc of California Inc BANC Q1 2026 Earnings EPS Surpasses Estimates Amid Solid Operating Performance UPS Q1 2026 Earnings Earnings Beat Estimates Amid Operational Efficiency Focus TG Therapeutics Q1 2026 Earnings EPS Disappoints as Stock Declines Fractyl Health Q1 2026 Earnings Narrowerthanexpected loss fails to lift stock as pipeline progress awaited CNSP Q1 2026 Earnings WiderthanExpected Loss Highlights ClinicalStage Cash Burn Lakeshore Acquisition III LCCC Holds Steady at 1036 Amid SPAC Market Uncertainty Blackrock MuniHoldings New Jersey Quality Fund MUJ Edges Higher Amid Steady Demand Cardlytics CDLX Inches Up as Key Support Holds A Closer Look at the Recovery Putnam Municipal Opportunities Trust PMO Climbs 063 as Income Demand Supports Price Fifth Third Bancorp Preferred Series K FITBO Holds Near Support as Yield Attracts Income Seekers FMAO Q1 2026 Earnings EPS Surpasses Estimates Amidst Challenging Interest Rate Environment SITM Q1 2026 Earnings EPS Surges Past Estimates with 22 Beat FLWS Q1 2026 Earnings Deep EPS Miss Fails to Deter Investors as Stock Edges Higher MO Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick XCF Global Inc SAFX Q1 2026 Earnings Narrow EPS Beat Sparks Cautious Optimism Digi Power X Inc DGXX Q3 2025 Earnings Losses Narrow as Operational Focus Intensifies Eli Lilly Reports Positive Phase 3 Results for Obesity Treatment Retatrutide Showcasing Significant Weight Reduction Compass Therapeutics Q1 2026 Earnings Narrowed Loss and Positive Surprise as Pipeline Progress Continues Processa Pharmaceuticals PCSA Surges 575 as Shares Test Key Resistance Level